research, on demand
Follow-up Q&A grounded in this page: price, AI take, research note, recent news, and sector peers. Anonymous, with a daily question cap. Answers are introductory context, not advice.
Sign in to generate research on PHARMDEKO — Vantis reads the filings, financials, news, and insider activity, and returns a sourced read in about a minute.
| Ex-date | Pay date | Type | Amount |
|---|---|---|---|
| 07 May 2018 | — | final | ₦0.05NGN |
| 18 Apr 2017 | — | final | ₦0.05NGN |
| 12 Aug 2016 | — | final | ₦0.15NGN |
| 24 May 2004 | — | final | ₦0.20NGN |
| 28 Aug 2003 | — | final | ₦0.10NGN |
NGN cash dividends are paid net of 10% withholding tax· Source: EODHD corporate-actions feed
No NGX corporate disclosures on record for PHARMDEKO. New filings appear here shortly after they're published on the exchange.
No director or insider dealing notices on record for PHARMDEKO. New notices appear here shortly after they're filed on the exchange.
No news for this ticker.
